Published on 8 Nov 2023 on Insider Monkey via Yahoo Finance
Does Enovis (ENOV) Have a Long Runway for Continued Earnings Growth?
The London Company, an investment management company, released “The London Company Small Cap Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. During Q3, U.S. stocks fell due to rising long-term interest rates, higher energy prices, and the Fed's message of higher rates for longer. In the third quarter, the fund declined 1.2% (-1.4% net) compared to a 5.1% decrease for the Russell 2000 Index. Both sector exposure and stock selection dragged the performance in the quarter. In addition, you can check the top 5 holdings of the fund to know its best picks in 2023.
The London Company Small Cap Strategy highlighted stocks like Enovis Corporation (NYSE:ENOV) in the third quarter 2023 investor letter. Headquartered in Wilmington, Delaware, Enovis Corporation (NYSE:ENOV) is a medical technology company. On November 7, 2023, Enovis Corporation (NYSE:ENOV) stock closed at $48.33 per share. One-month return of Enovis Corporation (NYSE:ENOV) was -3.86%, and its shares lost 8.33% of their value over the last 52 weeks. Enovis Corporation (NYSE:ENOV) has a market capitalization of $2.636 billion.
The London Company Small Cap Strategy made the following comment about Enovis Corporation (NYSE:ENOV) in its Q3 2023 investor letter: